<p>There is an increasing interest in using three-dimensional (3D) spheroids for modelling cancer and tissue biology with the goal of accelerating translation research. The goal of this study was to develop high-content imaging and analysis methods to characterize phenotypic changes in human cancer spheroids in response to compounds treatment and to optimize spheroid assay protocols for higher throughput. Specifically, we optimized spheroid cell culture protocols using low adhesion 96- and 384-well plates for three commonly used cell lines, and improved the workflow with a one-step staining procedure that reduces assay time and minimizes variability. We improved imaging method by using maximum projection algorithm which allows combination o...
<p>Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have be...
Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have been ...
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor pr...
There is an increasing interest in using three-dimensional (3D) spheroids for modelling cancer and t...
There is an increasing interest in using three-dimensional (3D) spheroids for modeling cancer and ti...
Objectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pathophys...
Objectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pathophys...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
none7noObjectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pa...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic s...
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic s...
<p>Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have be...
Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have been ...
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor pr...
There is an increasing interest in using three-dimensional (3D) spheroids for modelling cancer and t...
There is an increasing interest in using three-dimensional (3D) spheroids for modeling cancer and ti...
Objectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pathophys...
Objectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pathophys...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
none7noObjectives: Three-dimensional (3D) models have greatly improved our understanding of tumor pa...
International audienceA recent decline in the discovery of novel medications challenges the widespre...
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic s...
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic s...
<p>Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have be...
Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have been ...
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor pr...